ID

42581

Descrizione

GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01655628

collegamento

https://clinicaltrials.gov/show/NCT01655628

Keywords

  1. 15/09/21 15/09/21 -
Titolare del copyright

Sun Yat-sen University

Caricato su

15 settembre 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Stage IV Nasopharyngeal Carcinoma NCT01655628

Eligibility Stage IV Nasopharyngeal Carcinoma NCT01655628

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. the primary lesions of all patients were classified as undifferentiated, non-keratinizing carcinoma at the initial stage for treatment (who, 1991 criteria) and no distant metastasis was observed based on imaging studies before radiotherapy ;
Descrizione

Primary lesions initially classified as Undifferentiated non-keratinizing carcinoma | No distant metastasis before radiotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1402294
UMLS CUI [1,2]
C0679228
UMLS CUI [1,3]
C1334926
UMLS CUI [1,4]
C0205698
UMLS CUI [1,5]
C4071762
UMLS CUI [2,1]
C0027627
UMLS CUI [2,2]
C0332152
UMLS CUI [2,3]
C1522449
UMLS CUI [2,4]
C0332197
2. all patients had received standard doses of radiotherapy, were regularly followed-up after radiotherapy, and had distant metastatic lesions revealed by imaging studies;
Descrizione

Standard doses of radiotherapy | Regular follow-up | Distant metastasis revealed by imaging studies

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0034524
UMLS CUI [1,3]
C1442989
UMLS CUI [2,1]
C1522577
UMLS CUI [2,2]
C0205272
UMLS CUI [3,1]
C0027627
UMLS CUI [3,2]
C0011923
3. metastases were found more than 6 months after the end of radiotherapy, with the expected survival time of more than 3 months;
Descrizione

Metastasis found after the radiotherapy | Life expectancy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C2316983
UMLS CUI [1,3]
C1522449
UMLS CUI [2]
C0023671
4. in each case, no more than 10 metastatic lesions were found in the imaging studies;
Descrizione

Quantity of metastasis found in the imaging studies

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0011923
5. eastern cooperative oncology group (ecog) performance status was 0 - 1;
Descrizione

Ecog performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
6. the bone marrow functioned normally (wbc > 4.0×109/l, hb > 120 g/l, plt > 100×109/l);
Descrizione

Normal bone marrow function | White blood cell count | Hemoglobin measurement | Platelet count

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [1,3]
C0205307
UMLS CUI [2]
C0023508
UMLS CUI [3]
C0518015
UMLS CUI [4]
C0032181
7. the ecg results were normal, and the liver and kidney were functional.
Descrizione

ECG normal | Normal liver function | Normal kidney function

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0522054
UMLS CUI [1,2]
C0205307
UMLS CUI [2,1]
C0232741
UMLS CUI [2,2]
C0205307
UMLS CUI [3,1]
C0232804
UMLS CUI [3,2]
C0205307
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients were excluded if they had central nervous system metastases;
Descrizione

Central nervous system metastases

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0686377
2. uncontrolled infection; underlying disease that was severe or life-threatening;
Descrizione

Uncontrolled communicable diseases | Severe disease | Life-threatening disease

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0205082
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C2826244
3. the patients were pregnant or lactating;
Descrizione

Pregnancy | Breast feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
4. ecog perform status ≥ 2;
Descrizione

Ecog performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
5. the patients who are suffering from auto immune diseases or patients who need to accept glucocorticoid treatment.
Descrizione

Autoimunne diseases | Adrenal cortex hormones

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004364
UMLS CUI [2]
C0001617

Similar models

Eligibility Stage IV Nasopharyngeal Carcinoma NCT01655628

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Primary lesions initially classified as Undifferentiated non-keratinizing carcinoma | No distant metastasis before radiotherapy
Item
1. the primary lesions of all patients were classified as undifferentiated, non-keratinizing carcinoma at the initial stage for treatment (who, 1991 criteria) and no distant metastasis was observed based on imaging studies before radiotherapy ;
boolean
C1402294 (UMLS CUI [1,1])
C0679228 (UMLS CUI [1,2])
C1334926 (UMLS CUI [1,3])
C0205698 (UMLS CUI [1,4])
C4071762 (UMLS CUI [1,5])
C0027627 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C1522449 (UMLS CUI [2,3])
C0332197 (UMLS CUI [2,4])
Standard doses of radiotherapy | Regular follow-up | Distant metastasis revealed by imaging studies
Item
2. all patients had received standard doses of radiotherapy, were regularly followed-up after radiotherapy, and had distant metastatic lesions revealed by imaging studies;
boolean
C1522449 (UMLS CUI [1,1])
C0034524 (UMLS CUI [1,2])
C1442989 (UMLS CUI [1,3])
C1522577 (UMLS CUI [2,1])
C0205272 (UMLS CUI [2,2])
C0027627 (UMLS CUI [3,1])
C0011923 (UMLS CUI [3,2])
Metastasis found after the radiotherapy | Life expectancy
Item
3. metastases were found more than 6 months after the end of radiotherapy, with the expected survival time of more than 3 months;
boolean
C0027627 (UMLS CUI [1,1])
C2316983 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,3])
C0023671 (UMLS CUI [2])
Quantity of metastasis found in the imaging studies
Item
4. in each case, no more than 10 metastatic lesions were found in the imaging studies;
boolean
C0027627 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0011923 (UMLS CUI [1,3])
Ecog performance status
Item
5. eastern cooperative oncology group (ecog) performance status was 0 - 1;
boolean
C1520224 (UMLS CUI [1])
Normal bone marrow function | White blood cell count | Hemoglobin measurement | Platelet count
Item
6. the bone marrow functioned normally (wbc > 4.0×109/l, hb > 120 g/l, plt > 100×109/l);
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0205307 (UMLS CUI [1,3])
C0023508 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
ECG normal | Normal liver function | Normal kidney function
Item
7. the ecg results were normal, and the liver and kidney were functional.
boolean
C0522054 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2,1])
C0205307 (UMLS CUI [2,2])
C0232804 (UMLS CUI [3,1])
C0205307 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Central nervous system metastases
Item
1. patients were excluded if they had central nervous system metastases;
boolean
C0686377 (UMLS CUI [1])
Uncontrolled communicable diseases | Severe disease | Life-threatening disease
Item
2. uncontrolled infection; underlying disease that was severe or life-threatening;
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0012634 (UMLS CUI [3,1])
C2826244 (UMLS CUI [3,2])
Pregnancy | Breast feeding
Item
3. the patients were pregnant or lactating;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Ecog performance status
Item
4. ecog perform status ≥ 2;
boolean
C1520224 (UMLS CUI [1])
Autoimunne diseases | Adrenal cortex hormones
Item
5. the patients who are suffering from auto immune diseases or patients who need to accept glucocorticoid treatment.
boolean
C0004364 (UMLS CUI [1])
C0001617 (UMLS CUI [2])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial